Applying CRISPR-based genetic screens to identify drivers of tumor-cell sensitivity towards NK-cell attack
Preprint
- 27 January 2019
- preprint
- Published by Cold Spring Harbor Laboratory in bioRxiv
- p. 531962
Abstract
Natural killer (NK) cells distinguish cancer cells from healthy cells using an array of germline-encoded receptors that interact with ligands expressed on target cells. A balance of inhibitory and activating signals transduced by these receptors regulate NK cell function to provide anti-tumor immunity while maintaining self-tolerance. However, knowledge of the spectrum of factors regulating NK-cell-mediated cytotoxicity, including the contribution of specific ligands and regulatory mechanisms for their expression on tumor cells, remains incomplete. Here, we apply a genome-wide loss-of-function screen in tumor cells using CRISPR/Cas9 technology to identify the factors that promote NK-cell cytotoxicity towards tumor cells. We established the drivers of tumor-cell sensitivity towards NK-cell attack (TuSeNKA) screening approach using the chronic myeloid leukemia (CML) cell line, K562. Interestingly, we identified B7H6, the ligand for the activating NK cell receptor NKp30, as the single factor whose loss resulted in increased resistance of K562 cells towards NK cells. Our study shows that combination of CRISPR-based genetic screens with NK-cell cytotoxicity assays is a valuable tool for identifying functionally relevant NK cell-tumor cell interactions, paving the way for further investigations that unravel the complexity of signals that promote NK-cell recognition of transformed cells and develop therapies that target these modes of tumor-cell killing.Keywords
This publication has 38 references indexed in Scilit:
- Natural killer cell biology: An update and future directionsJournal of Allergy and Clinical Immunology, 2013
- Multiplex Genome Engineering Using CRISPR/Cas SystemsScience, 2013
- Tyrosine kinase pathways modulate tumor susceptibility to natural killer cellsJournal of Clinical Investigation, 2012
- Importance of NKG2D-NKG2D ligands interaction for cytolytic activity of natural killer cellCellular Immunology, 2012
- Natural killer cell cytotoxicity: how do they pull the trigger?Immunology, 2009
- The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humansJournal of Experimental Medicine, 2009
- Up on the tightrope: natural killer cell activation and inhibitionNature Immunology, 2008
- Expression Analysis of the Ligands for the Natural Killer Cell Receptors NKp30 and NKp44PLOS ONE, 2007
- Immune surveillance of tumorsJournal of Clinical Investigation, 2007
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002